富祥药业 (300497.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(富祥药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 294,461,087.88341,983,786.64340,430,593.83323,230,809.27430,793,596.45457,727,408.99397,918,173.64
 营业收入(元) 294,461,087.88341,983,786.64340,430,593.83323,230,809.27430,793,596.45457,727,408.99397,918,173.64
二、营业总成本(元) 342,371,895.24387,178,468.94347,981,386.08409,802,665.27449,738,815.81483,250,258.87431,474,684.77
 营业成本(元) 268,557,986.98322,559,071.75288,911,075.19296,881,995.70369,011,954.95416,519,952.10356,203,411.79
 研发费用(元) 20,149,463.5618,853,361.2715,874,928.9633,950,903.9123,862,336.2320,162,210.1419,477,717.76
 营业税金及附加(元) 4,057,738.133,786,455.204,783,074.125,203,642.904,771,100.613,365,615.323,315,143.81
 销售费用(元) 4,750,417.885,540,076.902,355,625.156,162,222.509,572,618.2910,616,690.018,988,432.14
 管理费用(元) 34,662,465.9330,670,852.0229,328,497.6557,408,576.9934,098,434.5036,187,082.9632,622,160.70
 财务费用(元) 10,193,822.765,768,651.806,728,185.0110,195,323.278,422,371.23-3,601,291.6610,867,818.57
  其中:利息费用(元) 9,850,296.849,932,733.9310,806,535.2310,494,594.5810,764,927.1810,546,862.4810,224,924.45
  其中:利息收入(元) 1,396,852.051,738,393.332,339,089.022,491,536.382,201,982.492,129,361.632,471,131.06
 资产减值损失(元) ----49,910,634.271,515,946.51--
 信用减值损失(元) 838,602.90-1,636,683.51-443,849.781,833,552.34-2,053,816.51-3,394,396.15-755,810.86
三、其他经营收益
 加:公允价值变动收益(元) ---751,954.981,834,042.48-729,359.74-1,197,264.37
 加:投资收益(元) 43,794.52-1,235,854.14110,650.16-11,807,816.39-1,338,426.58-3,681,764.06665,887.43
  其中:对联营企业和合营企业的投资收益(元) ----11,756,455.96---
 资产处置收益(元) ---83,385.34---7,089.69
 其他收益(元) 5,567,581.5723,463,831.4611,986,174.242,299,702.85808,643.962,610,863.091,048,401.69
四、营业利润(元) -41,460,828.37-25,472,230.864,102,182.37-143,321,711.15-18,178,829.50-34,086,183.99-33,802,386.93
 加:营业外收入(元) 108,825.79197,614.3377,134.53150,385.52230,722.88230,516.51307,002.30
 减:营业外支出(元) 295,576.4176,577.51350,904.973,274,319.43874,796.32467,145.6284,134.26
五、利润总额(元) -41,647,578.99-25,351,194.043,828,411.93-146,445,645.06-18,822,902.94-34,322,813.10-33,579,518.89
 减:所得税费用(元) 536,328.16932,476.004,568,321.44-16,098,653.896,147,437.1325,115.2611,314.19
六、净利润(元) -42,183,907.15-26,283,670.04-739,909.51-130,346,991.17-24,970,340.07-34,347,928.36-33,590,833.08
(一)按经营持续性分类
  持续经营净利润(元) --26,283,670.04-739,909.51-130,346,991.17-24,970,340.07-34,347,928.36-33,590,833.08
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -39,615,709.98-23,927,700.361,468,451.11-119,163,172.88-21,962,365.13-29,527,570.99-30,146,940.29
  少数股东损益(元) -2,568,197.17-2,355,969.68-2,208,360.62-11,183,818.29-3,007,974.94-4,820,357.37-3,443,892.79
 扣除非经常性损益后的净利润(元) -44,753,080.66-39,433,737.39-10,002,144.60-114,633,235.40-22,400,820.84-29,232,522.76-31,328,355.26
七、每股收益
 一、基本每股收益(元) -0.08-0.04--0.22-0.04-0.05-0.06
 二、稀释每股收益(元) -0.08-0.04--0.22-0.04-0.05-0.06
九、综合收益总额(元) -42,183,907.15-26,283,670.04-739,909.51-132,979,222.69-24,970,340.07-34,347,928.36-33,590,833.08
 归属于母公司所有者的综合收益总额(元) -39,615,709.98-23,927,700.361,468,451.11-121,795,404.40-21,962,365.13-29,527,570.99-30,146,940.29
 归属于少数股东的综合收益总额(元) -2,568,197.17-2,355,969.68-2,208,360.62-11,183,818.29-3,007,974.94-4,820,357.37-3,443,892.79
公告日期 2024-10-242024-08-292024-04-292024-04-292023-10-252023-08-312023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院